Clinical Trials Browser

Phase 2 × OTHER × Platinum Resistant Ovarian Cancer × Clear all

NCT06973421 2025-05-15

Phase II Study of Utidelone Plus Fruquintinib Combination Therapy for Platinum-Resistant Recurrent Ovarian Cancer

Phase 2 Not yet recruiting

Platinum Resistant Ovarian Cancer